Continuing our weekly clinical trial round-ups, here we look at developments in life sciences research and development announced during the week of 29th January to 2nd
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh